A. E. Eskazan, "Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?," BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.84, no.8, pp.1635-1638, 2018
Eskazan, A. E. 2018. Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.84, no.8 , 1635-1638.
Eskazan, A. E., (2018). Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.84, no.8, 1635-1638.
Eskazan, Ahmet. "Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?," BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.84, no.8, 1635-1638, 2018
Eskazan, Ahmet E. . "Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.84, no.8, pp.1635-1638, 2018
Eskazan, A. E. (2018) . "Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.84, no.8, pp.1635-1638.
@article{article, author={Ahmet Emre EŞKAZAN}, title={Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?}, journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY}, year=2018, pages={1635-1638} }